4-Methylumbelliferone as a Treatment for Chronic HBV/HCV
NCT00225537
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
160
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis C
Chronic Hepatitis B
Interventions
DRUG:
4-Methylumbelliferone (Heparvit®)
Sponsor
MTmedical Institute of Health
Collaborators
[object Object]
[object Object]